drugset / Trial / NCT00584987

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis

NCT00584987

Phase 4 Completed 64 enrolled University of Chicago GlaxoSmithKline · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

We hypothesize that once daily use of oxymetazoline will not cause significant rhinitis medicamentosa and that the combination of fluticasone furoate plus oxymetazoline leads to faster relief of nasal congestion secondary to perennial allergic rhinitis than the use of fluticasone furoate alone.

Timeline

Start
2007-06
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Furoate Other / unclassified 110 mg Intranasal
Comparator Oxymetazoline Other / unclassified 0.05 % Intranasal

Indications